The attraction of chemokines as a target for specific anti-inflammatory therapy.
about
Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous SystemsChemokines as Therapeutic Targets to Improve Healing Efficiency of Chronic WoundsNaturally occurring anthraquinones: chemistry and therapeutic potential in autoimmune diabetesAndrographolide attenuates LPS-stimulated up-regulation of C-C and C-X-C motif chemokines in rodent cortex and primary astrocytesEffect of plant neutrophil elastase inhibitor on leucocyte migration, adhesion and cytokine release in inflammatory conditionsThe chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function.Obesity enhances eosinophilic inflammation in a murine model of allergic asthma.Effects of CXCR4 gene transfer on cardiac function after ischemia-reperfusion injury.The yin and yang of chemokine receptor activation.3D profile-based approach to proteome-wide discovery of novel human chemokines.Characterization of the rainbow trout spleen transcriptome and identification of immune-related genes.Chemokine expression by small sputum macrophages in COPD.Cytokine & chemokine response in the lungs, pleural fluid and serum in thoracic surgery using one-lung ventilation.Induction of host chemotactic response by Encephalitozoon spp.Catenarin Prevents Type 1 Diabetes in Nonobese Diabetic Mice via Inhibition of Leukocyte Migration Involving the MEK6/p38 and MEK7/JNK Pathways.Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammationCD192 gene variant and susceptibility to cervical cancer: a meta analysisChemokine polymorphisms and lymphoma: a pooled analysisBlockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats.Down-modulation of primate lentiviral receptors by Nef proteins of simian immunodeficiency virus (SIV) of chimpanzees (SIVcpz) and related SIVs: implication for the evolutionary event at the emergence of SIVcpz.Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists.Chemokine receptor antagonists: Part 1.In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study.Analysis of the pharmacokinetic/pharmacodynamic relationship of a small molecule CXCR3 antagonist, NBI-74330, using a murine CXCR3 internalization assay.Obese donor mice splenocytes aggravated the pathogenesis of acute graft-versus-host disease via regulating differentiation of Tregs and CD4+ T cell induced-type I inflammation.Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers.Protein levels of CC chemokine ligand (CCL)15, CCL16 and macrophage stimulating protein in patients with sarcoidosis.
P2860
Q26744762-7EC1C726-4A74-4327-AE84-B5B8C4072B80Q26778690-B2D482D2-0F31-4778-8537-D0BE02973954Q27022572-52E33D67-6C90-4718-A0E4-43B5652CDBEEQ27303312-C0893A9A-BBA8-43BD-9D33-7CAC5C9F44FEQ28566238-339075DB-E065-44D2-A03B-21B95FE12D98Q33595360-ED372DE6-6D2E-4AA9-9318-26AE7AFB10E2Q33685925-282BBAFB-EC67-4B1C-A39C-6860A2FA4FB8Q33745154-8BC40763-AE06-4FDA-989C-8832E9CE5748Q34060799-76B361C2-0396-4093-8B13-6465C1F0153AQ34269071-28C70337-4B7F-46AD-925B-EBC5BA64F50BQ34336531-E0EA6A29-7AB5-42CA-825A-966E8F05FEFAQ35136709-59A15BE5-BBE9-4375-BB61-9EAF1EA1851DQ35658319-A031D897-14CE-4C6F-BA45-2CA279EAFDDBQ35783912-F7BE7D48-4D3D-45C0-B41B-2E0CFCB5B95BQ35793015-F9C64EFC-C245-46F1-8130-3D40E6F4B0CFQ35849570-6FB0163C-E9E6-441E-A93D-94EBA9E0F1D5Q35959197-A49FF57C-2366-4780-9B82-4374F1C49B10Q36237839-F61340AA-253D-4BBC-95BF-3D844976BB2FQ36495135-14EEE747-FF12-4097-A9E0-E0017C629925Q36871889-73D652D2-4439-4C0D-ACC0-9FA1A626D5D5Q37431503-CD7B3133-B48D-4DF3-AED8-23C9A014A94FQ37481238-166B0412-971D-4ECD-AACC-1BCB0F01BF29Q41533540-6F66FF00-C1A6-44CA-A07A-963FB4DB28E6Q41820935-3567F106-74F1-4AE5-B26B-1DF45FFD85D6Q47157951-75203945-750B-4A87-A977-90C387BD73EBQ51795174-F8D036F5-3EF7-42C3-986A-9B4C35C949ECQ51818416-87679FFB-B3F9-432E-B339-00C5F8EF8C21
P2860
The attraction of chemokines as a target for specific anti-inflammatory therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The attraction of chemokines as a target for specific anti-inflammatory therapy.
@ast
The attraction of chemokines as a target for specific anti-inflammatory therapy.
@en
type
label
The attraction of chemokines as a target for specific anti-inflammatory therapy.
@ast
The attraction of chemokines as a target for specific anti-inflammatory therapy.
@en
prefLabel
The attraction of chemokines as a target for specific anti-inflammatory therapy.
@ast
The attraction of chemokines as a target for specific anti-inflammatory therapy.
@en
P2860
P356
P1476
The attraction of chemokines as a target for specific anti-inflammatory therapy.
@en
P2093
James E Pease
Timothy J Williams
P2860
P304
P356
10.1038/SJ.BJP.0706475
P407
P478
147 Suppl 1
P577
2006-01-01T00:00:00Z